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Tmnspkacadon has signiflClUldy advanced in the p8SC 30yems. Thuvailability of 
T<ell-dicectccl immunosuppressive tl8enrs (FKS06. Rapamycin, Cyd06porine, 
Azarhioprlne)huallowedpancrearictDDSpIantationtO'become-.nacceptedthempew:k: 
approach for treatment of rua~sK In recenc years, the development of ptocedum to 
ifo1ate Luse oumbe!:$ of pancreatiC islets bas made 1, possible 1:0 initiate dinicn1 trials 
.for ceUufar replacement of paocrcatic en<10cri0e f\.u1ction-l-6Ttansplanration of panac-
ark islets is the most focused approach to treat diCLber.s and may offer a number of 
adYanta.ses ovettraD$pIantaeionofthe wboJe pmcreas asnKpdmacily~ gcatt. 
In addicion. to me pocentiallOt ayopreservation and islee "D~1DfIg"I in vitro pretreat· 
ment c£ free c;ellular grafts is more fetsihIe than with soLid orpns. Finally. one QI.Q, 
elimioate thereqWrtmeo.tfotWSC\l1ataodductU atWtomO..es which must accompany 
the UUlSplamation of did pancreas grafaJ. 
It is well.recosnized chat all. panc.reas pets are hishly ao.tigeoic;.1.8 Although o.ae 
mipc pndict dw me celluIa.r pits ~uld be fer antigeoic; than a primarUy 
~ized solid prgul,rm, me op,poeitc has proven to be true.I" Cellula(' gratis are 
even more ant"isenic £han the whole pulCLeIS if one uses tejeaion-free smvival and 
function as the cti(ecia fOt judging gmft immunogenic.ity. Approaches to reduce 
imuwnogcnicity of the isle; ,18fts. indud.inc smt ptette;U:meIlt with monoclOOal 
antibod,.U.9-ll ill vicro culture cedmiques. 4.to-l' ulaavio1et im.diation of the gram. 1-\01, 
mlcroenapsulacioo. "..20 and isoJadon of hand~picked 8-ceIJs21,22 ha.ve feSUlted in 
prolonged gmft swvival, bur these apptOOChes have nor reliably prevented gr.Ut 
zejection. The ind~on c£ dOOONpecific tranSplantation toIetuCe ACtO$i MHC 
dupacities, or even species barrielS, has been rugsested as a poeential app:oach to 
~tnethelimitationofgtafDcrejectionKDfDodateIthtoolysaueofttuesystemic:<lltllr­
specific uansplanmrion rolemnce bas been that assoc:ittecl with chimerism. the engroa.£t-
mentof'bonemurowstemceIlsinaronditionedteeipient. ThetsSOCiatiOQofchimerism 
mel tOlerance will be the roru. of this chapter. 
The recosnltion !:bat bone marrow stem cells pocaess a uniqw: property to induce 
5YScemicandpermanentt'lanSplantationcoIetalXetodOllOChistocompt.tibilltyllJtugens 
was made in the late 194& aod e:I.I.'ly 1950s. Owell. detected.mixed ICd. blood cell 
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BOlle Marrow ChimMsm and ~k;tealic Istet Grafts 
chimerism in (ratemel twins which .hared 11 
common placenta (frccmanin cau1e) and QIXl-
dueled that this was posSible only if hemaropoi-
etic stem cells had been ~ in utero. zs 
This effect peaisted in these animals duoughout 
their lifespan. The implications of this phenom-
enon Cor cransplantation immunolO8Y would. 
provo to be pt"OtOund.: if donot bone maaow c;ells 
eouJd be qtafced itt normal =lplencs, dlc:Y 
would ROC be rejected. bue inscead would pe!Sist: 
in a mllt\.ll\l state of coroietaDCC. 
ContemporaneouslvgB~KBmu:aKnd 
Medawar became aware of Owed's Oocerv.fion 
when [bey were -.sked by the AsdculruraI Re-. 
sealCh Council todevelop a model codistiDsuith 
monozy8otic: from dizypic aQ twjns. Ie was 
impotWlt to the catde indusuy hec:a.1JSe ".&ec-
martin- (chimeric:) ccJ.t; WeJ:e vittUSlly elways 
Sterile and therefore not cr:onomlcal ro raise. 
BUlinghau:n. Brenc end Mcda1rar had ckvclo,pcd 
.. mecllod to use skin graftias to ped'oan hisco-
compa.tibil1cy t)'ping. They had. demonsuaud 
skin grafc rejection in the p~ofbisrocom­
pacibility d.ilfe[CQCC$. HOWCMt, to rheiuu.rpriae 
tbq JOund that daySOtic: ~ja g.cde (IC-
cepted skin ptts &om their sibling jusr as 
~llyasdid mOl¥)ZJsOOc(kientica1} twins. The 
presence of donor chimerism had rendered the 
rec;ipients tolerant. Tbeyimmediatelyattelnplled 
to mmsfer booe marrow cells into newbom tl.lice 
co detennine whether dooet-specihc skin ,m{[ 
5UlVival could be achieved. This Jed to the report 
of-actively acquired tolerance offoteisncelb" in 
which tnruplantatioo of Major eistlClmpa~ 
ibillty Complex: (Mliq........djspem bone mu· 
rowsrerncellsinto neonACal.tecipientznic;einchx:ed. 
specific and systemic toIerante co the d,oQarw.ith 
preservatioD. of immtl~e to Rjec:c 
senetica.Uydiffe.renc thirdput)' ,rafcsftomort. 
donoa.'" Mo~Kthe ~ was .albIc md 
pelSisted ioto the adult Jj£e r:i the n:cipitnt. 
The fetus and newborn poMaI a pcivilepi 
Slate in which DO (;ooditiOll.inJ is RquIccd to 
achi~ mgraft.menc ofhooe mmow cells in the 
form of chimerism. In the O'IOUSC, this Item ~l 
engmfi:meotc:an be adr~ Wlti172 houn lff~r 
birth. In me hUllWl fetus, thls oo;u[S until 16 
weeks of gc5tation. ~r that, approadles to 
ccndidon the tecipimt or -make spa.ce"toalJo'w 
boDe manow Item ccn. to eogmft must be 
ut.illzcd (amdilirmbJg). 
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Aftenhe pioneerin,e work ofBillinJ;tham et 
at in neonatal mice, appcoa.chcs to achieve sirnilat' 
chimerism in adult recipientS Wl!!re repomd_ 
Conditioning approaches to allow engrafunent 
of donor stem celIs .ioc1uded total body irtadi3-
don,Z'.Z6 tOtal lymphoid irradiatiOtl,21 end 
pha.trnawJogic cytO.teducdve approaches. i.e., 
cyc:1opbosplwnicle.:2a With each of these: ap-
pmadJes, donot-spcci6c ttanspbama.tion toler-
ance to subsequent solid ocpn or tissue grafts of 
donor-type wa.s achieved. The tolexance induced 
was scable,synemic.and specific mrthe donor. I.: 
diet not requjre the ust of cluonic nonspecifIc: 
iaummosuppressive agt1lII. Hence the recoSni-
tioa that chim.eclsm was essocIaced with toler-
ance for tis5ue anlsolid otsan graih. 
It is now vvelI accepted dw full replacement 
of the immune sysccm« the recipient with that 
or clonor (fo01 aHtJgmric rhittltritm) results in 
systetnic:doncwpecitkaanspIanradon tOlerance. 
However, this sam is complkated by a relative 
state pfredpient~K~9·rDnledo­
norT-lymphocyres which develop in the .reclpl-
em: are restriclCed to interacting with 
aatigen-presendngcells(APC)ofthe host. With 
1Vll replecemenr:ofaffbone-marrow-<ieriwd~ 
only donoc APCs&te pmtftt. Asa r:esWIC, Prima1:7 
immnne responses which .rely on.APCr, includ-
iftg e.otibocly produaion,JZ ant.iviml mponsesI~ 
and lW'Vival are sisni6Q11ldy impaited, result-
in8 in :a. state of reladve recipient 
immunoincompeteoce.B 1'bete!ore, tOlerance 
ancl immunoecmpet:ence GlC C1YO indepecdellt 
v8tiebles. 
'thG pKreaen~eofpFDaseneie bone mAfrowcel1s 
in~tencewitballopeic;bonemurowE1ffbrzg 
JJi1lllritwl) re.sults in sim.iI..r ~i~ donor-spe--
eWe ttansplantation tolecance toe solid organ 
,ra&s with the advamtat that ceclpient immu. 
nOCOlDpCcenceisp1l!5etved.Theapproprlatehosc-
derlwJd APOJ ace pltSCllt mel .. state of mutual : 
COtOleraoa: is induad. The donotaod. host bone 
man:ow seem alb co-ensraft aDd function co 
produce multilineage mixed chimer.is.m. A mix-
cure otdonor and cecipient red blood celIs, platt!-
lets. B-ceUs, T -<e1ls.NK: cells, macrophagesand 
other APes, granulocytes a.ad monocym em be 
deteCted (manusaipt submitted). In .tOOns 
conuast mfUIly alloseDtic chimeras. mixed.no-
geneic chimeals exhibir superIor immunocom-
p~tence for antibody production, antiviml 
9i€S~d9d~~ 'ON ~s~ QV!SQ11 3NNVZnS D~n 
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teSpOI1Sl!S, and survival,Jl..a3 Mosc importantly, a 
relative resiamnce to graft versus host (GVH) 
di.scase is P£eSent In mixed allogeneic ch.imems 
due to mechanIsms which have me }'I!t been 
elucidared. U.»..n.51 Similar IeSistance to GVH 
disease Iw been reponed in human recipients of 
allogenei( bone marrow who bydwlce rec:onsti. 
ruted as mixed chlmttaS.J4 
Mixed chimerism can be achieved. by 
coadminiHl'ation of syngeneic plus alloSene.tc 
bone marrow following conditiODinS with coral 
body imadiation (l'BI}.n tmllcplaAClLcion of 
ra~ allogeneic: bone maaow fonowiDJ 1:0-
w lymphoid irradiation ('I'Ll), 11 or following 
tdlnlnilm.tion of unuemd EqK~F bone 
marrowinc:oojuaccicmwitblow-cbeir.r:adilltion 
plus cydophospha.mideZS or mooodona! and.-
body. ~ In each of chese widely diHetent ap-
pt04ches, the induction of donor-specific 
cmo.splantatiOD T:olerancepIM l'CSisance to GVH 
disease 'NIlS observed, ~infoIdns the A~"pKsso­
ci&ti.on of tolerance with tbimcrism. Most im-
portantly. the presence of dUmcr.ism, no matter 
how low the level, cooCcm:d stable sysmnic 
dODQWpccific: craosplantation toletance. The 
m1cranccinduccd WIIS notinaememal,bot tathel:' 
tn all .... 1ItIne c:£rect. 
EXPERIMENTAL PROTOCOL 
, 
~~~~ow ve ... . 
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The E'l'\l1\Splanmion of bone .marrow cells 
aaosnenogeneic barrieISW beendemonstmted 
to produce bone marrow msc:ue following lethal 
Uradiation.J'." As in allogeneic chimecas, the 
presence of xeno~eic: chimerism is associated 
with dteinduc:donofDdonor-s~inc: traospla.nta.-
tion toletancc to solid orpn or tissue gnfu.'!H1 
Uncil re«ntly t xenogeneic chimerism was lim-
i~ by a.osicnt engm{tment of the donor bone 
marrow cells and. mfecior: recipient survlval.!Ml 
It hes noW bcenreponecl that Pte administration 
of 40 x 10' ra~ fllt bone marrow cells lnm 
Bl0lllQuxteQpientscondidonedwith950ads 
oflBl (rat -+ mouse) (FiS. 1) resulted in stable 
fully xenoSeneic: chimerism. excellent survival, 
resIstaoce to GVH cfuease, tnd the induccion of 
StabledonoNpedfic c1.'8mpJanw:ion coJenmce.. ~1 
latT.wI matW'Btionproceededina phenotypi-
CIlly normal tUhion In me chimeric mouse re-
cipients, as evidenced by an jnunaKtylre-s~ning 
profile by flow cytOU1etry in die thymus and 
mature profile in the periphery (Fig. 2). Most 
imporwttIy. the tIlc-derlved Iymphcx;ytes wue 
. ./tnItJiouO,tolemntco both reOplenc mouse~ 
donor fat antisens, yet fully-ftaCtive to MHC-
c:l.i.cparate third party mouse and rat e.ntisens 
illdi<:a.ting that mouse and rae ate DOt seen as 
generic species but instead in aD MeC·~ 
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MIXED XENOGENEIC CHIMERAS 
+ ~~I .. Ak ~"f" 
RAT ~
STABLE CHIMERISM (>12 MONTHS) 
. . 
NORMAL T CELL MATURATION IN THYMUS 
(BOTH .RAT AND' MOUSE) 
DONOR·SPECIFIC TOLERANCE 





specIflc mshion when toleranp! is iodtred across 
a species baIrlel'42 (ma.IlUSCl'ipe in preparation). 
Mixed xenogeneic chimew(mouse + tat'" 
mouse) ha.e been prepsted by CXIIlCbninisa!Dns 
T -cell-depieted syngeneic mouse plus untreated 
rat bone marrow to mouse=d.pientscondicioned 
byqBftfB·PFK"DprKablex~ejDmulcilin~ 
chime.ds.m tm.'18ins &om 1. to 569' rat foa: 
indMdual redpiencs bas beendemoLlluated. As 
in mixed.a1loseneic chimau,any level ofdccec:t-
able :xeno,encic ~C!riRfa was associacec1 with 
ItGble, systeinie donor-specific uaosplantation 
coleraace in vivoancJ in vItro. Most impoa:antiy, 
mmcJ xenogeneic chlmeras exhibited superior 
immrlllClm~I prob.bly fOr teuons simi· 
lar to thoce obKncd In mixed alloJeneic clUmc-
ras. AlthoughuncttatedmtbonemanowceI1sare 
acLniuistemi, c:hel'e is no evidence for GVH, 
suggaUng we cherc is a resistmce to GVH 
~rossasp«iesbanie1DKMlxedxenogcneicchigneK 
DIS accept donor~iSc sldt.l gn.fi:.t. but reject 
MHCdispua.ce dlied patty mouse and rat skin-
gIaftswiEbatimeCOI..JaesimiwroUll.tnaftipulac 
mit:e.45 
Althoush si8rufiCtlnt pr08re5S has occtu:red 
In aansplanmion in the past 30 YeaIS, t'WOmajor 
limitations exist: (1) there is a critiCal shortage of 
allo8fneic donots; and (2) rejection OCCl.lts in 
spice of conwntioDAl mulrimodal immunosup-
p-eaioo. These lhnitaticns are especlaUy true ror 
cellular grafq. The inducclon. of donot .. pecific 
nNlSpt..nr:acicm tolerance across species dispari-
ties bas heeLl.us&Csredas. potential app~h CO 
overcome mese limitations. 
lleccAtlY. 6illy;lllCOOJCOCic cbimttism was 
applied to .induc:e coletancc for panacaclc Wet: 
~ Pmnancnt, rcjea:ion-6:ee gxaft iUr-
vmI (:> 9 months) was demomnated when 
noohandplckcd ~c islet nnogmfts weIC 
traDlpl3nccQ in fully mlOgeneic (mf ... mouse) 
chimens. 42 In this expedm.ent. c:bimew were . 
pnprcd end typed mr chimerism 81: 6 weeks . 
(Pig. 4). Diabetes was then induced USillgasin&1e 
dose ofjntraveJlOUSsttl'lplmOtocin (165m&1k&). 
.After, to 7 days of docwnented hyperslycemia 
(blood glucose :> 300 msldl), either s donor-
speciSc oc MHCdispatate thitd party islet xe-
nOBraf{ placed llnder the renal "psule. 
. MHCdisparate thicd pany 8m" were mpidly 
reject«l(mediansurvivaldme .. ~c:f:ayKF in a time 
courseslmilutOunmanipulatedBIOmicewbi.le 
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c:epucl (Pi,. 5). To document that glucose !to-
JDeOItIISis was maintained by the islet xenopfr:s 
and wssnocduero regenerationo.ffitnctioninthe 
asclve panaeatic e~rine tissue, tf:anAptKn~ 
nephJ:ectomy 'M.I perfo.aned Itt !l1!1~ ame 
poinESCfig. 6). In all redpiems analyzed fiootn 90-
270days (n.8), hyperglytemiarecumd, cbeteby 
confirmiDg fu.nctiooal ~mty of che islet %8-
nogralts (Pis, 7). The islec arata and nati~ 
panaeasw~ebminedimmunohiKstochemicy 
usins immunope:oxidasestain.s to dmcc insulin 
production- Normal appeariDJ ~K~ 
timlcposiciWllOrinsulinprociuctionwup.EeSCnC, 
suppottingfuncdomlintegricyof' chcxcnopfts. 
No eYiclence.&x mononucleatcell iaflltratea 
could be detected. ~ expected, the narivc pm-
aeas bld no evidence fOr mruIin prod\ICaon, 
coEUirmingtbat ,lucosc homeost&$ia was io«cd 
meincained by dtcislet~K SimiJar long-
cenn reject1on-free p!t swvival anc1 nocDl 
function o£ donor-spcdfic ialet :xenografts bas 
been achieved. in oUxed xcoogcneic chimeras 
. (mouse + mt .... mouse).« Hence, this apptOaCh 
for toIeranc:e- induction has ptoWn effective to 
.now peaDJmCIIt 5U[Viwl and function of islec 
g~K 
Pancreatic fA~t Cell Tl2nsplslntation 
It hAs become appuem that althoush T-
cell..ditected anti.re;«tion therapy 1m lNde a 
sisoifiwtt improvement in,gn& survival, pe1'a 
.manent rejl!(tion-fi:ce grafi ~ has not yet 
been achieved. Ap1ts dil'eC= at other media-
tOrs in ~he complex n:jecaon pathway, i.e., 
cytokil1es, amigen-presendng cells, or B-lym-
phocyces, in combination with 'I' -ceU direcnld 
imrnUDOSUppeessiveagentl(PKS06,c:ydosporine 
A, RapamJcln) ma.y offer the optimal cOOlbioa-
cion co .chine permanent rejection-free graft 
survmJ.. If n«, chcuse ofol1el:enular graf't{bone 
macrow) IX) Kind~e tolerance m strain and even 
species disparities may provide en approacb to 
achic:w:~mtg1CafKtejecrion-fteesurvivalKofother 
cellular gnCts. i.e., pancreatIc uletS. 
The aansplam:acion ofbone JDa.m)W' cells to 
treat malignancy. leem cell failure. and genetic 
defeas IOpresetlts me .lUst successful clinical 
application of cellular tranSpJs.ntlttion. 47 Mer 
the demo1l$taLtlon ebat rescue from lethal irra-
diation could be aehieved usitl8 the intravenous 
injeaiooofbonems.trOWcells, evidence~cwnu­
lated tha~ the -barrier"' co crensplanmtion 'pam-
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documtntedinMedawar'$ ezPcamentsgavefu.t-
th£r $uppoR to the pacadism that the hismcom .. 
pecibilitybatrlcrrocransplam:ationwasnottarally 
iosw:rnountablc. The pioncerlng work «Dr. B. 
Donna11 ThomBS and conea,ues applied these 
obsern.tions to the aansplanwioQ of cellulae 
booemanow pits fortfClltmel1tof'hematolo,sic 
maligJ:tanqand the field dbone marrow aans-
plantaci~n bc:ame a clinical lSlity." 
AltlioUJh bone marrow uansplantatloode-
vtlopd in parallel and sometimes diversem 
parhway fi:om aolid otpn tl'lJJS.Planr:a.don, a .te-
cent JIl1lt1JIl.recognitlon bG led to. metgiog of 
these tWO mas so that: the lessons of esacb can be 
shared by both. In miswq,itIsquiteappropciatc 
co sp«ubte d.t the use of OM cellular gralt, i.e. 
bone martOW. tnighc be applied to achieve pel'-
tnanent suMval of. IleCOOd ceUuIaJ! graft, i.e., 
pancre.t.tic GR 
The c:linical applIcation. ofbo.a.c martOW to 
prolong swvi~ or solid o~ fllografts has; 
besun· In a recent report, two patiew:s who 
~vedeiA-mm:hcd1iving·Ktcfatcddlalrbonc 
QIll'OW gmJis for hemadogk malignancy de-
veloped ~ tmlucc as a late complication of 
their chealochcrapy.e BOth 1V'CrC given .. lentl 
9L£6vG9Glv 'ON uij~ 
ARE THE XENOGENEIC 
ISLETS FUNCTIONAL? 
~~K~ 
• • WI' I 11. 
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aUograft from the sa.me OOnf marrow donorand 
ha:ve experienced ~jeaicn-free 8M cumttl 
withoutimmunosuppL'tS5io.n..Inpiooeeringsa.td-
ies, Barber ec al reported. prolongation of {enal 
allogl'Bfi survlval 'When cadavcclOIlOrbone mar-
tOW was edministerecl 10 days followin,c pW:e-
menr; of the rena.I Bratt in conjunction with low 
doKsecyclophosphamideK~S A~lCtltlmprove­
meat: .in smfr: surriwl was obsemd and mosc 
im~tlyKnosigniKSc::aotmotbiditFDKiKeKIdseI 
was observed when T -c;ell replete donor bone 
marrow ceUs were tdmin.inered. 
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